Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020

被引：2
|
作者：
Moneer, Osman [1 ,2 ]
Lee, ChangWon C. [1 ]
Avorn, Jerry [1 ]
Kesselheim, Aaron S. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon,Program Regu, Boston, MA 02115 USA
[2] Yale Univ, Yale Sch Med, New Haven, CT USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2021.8530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (08) : 867 - 885
  • [32] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2949 - 2970
  • [33] Three US Food and Drug Administration-approved therapies for chronic GVHD
    Zeiser, Robert
    Lee, Stephanie J.
    BLOOD, 2022, 139 (11) : 1642 - 1645
  • [34] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024
    Zinnet Sevval Aksoyalp
    Gizem Kayki-Mutlu
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, 398 (5) : 5077 - 5099
  • [35] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 867 - 885
  • [36] US Food and Drug Administration-Approved Laboratory Tests After Caronia
    Allen, Timothy Craig
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (11) : 1543 - 1544
  • [37] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (08) : 1619 - 1632
  • [38] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 2949 - 2970
  • [39] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 1619 - 1632
  • [40] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Liang, Fei
    Zhang, Sheng
    Wang, Qin
    Li, Wenfeng
    BMC CANCER, 2020, 20 (01)
12345